Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study ...Middle East

PR Newswire - News
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study
Summary of Study Outcomes ZIRCON Phase III study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) has met all of its primary and secondary endpoints The study delivered co-primary endpoints of 86% sensitivity and 87% specificity and 93%...

Hence then, the article about telix announces positive topline results of zircon phase iii kidney cancer imaging study was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study )

Apple Storegoogle play

Last updated :

Also on site :



Latest News
before 19 minute